The WACC of Karyopharm Therapeutics Inc (KPTI) is 6.9%.
Range | Selected | |
Cost of equity | 9.30% - 12.30% | 10.80% |
Tax rate | 0.20% - 0.20% | 0.20% |
Cost of debt | 4.00% - 7.00% | 5.50% |
WACC | 5.4% - 8.4% | 6.9% |
Category | Low | High |
Long-term bond rate | 3.9% | 4.4% |
Equity market risk premium | 4.6% | 5.6% |
Adjusted beta | 1.19 | 1.33 |
Additional risk adjustments | 0.0% | 0.5% |
Cost of equity | 9.30% | 12.30% |
Tax rate | 0.20% | 0.20% |
Debt/Equity ratio | 2.83 | 2.83 |
Cost of debt | 4.00% | 7.00% |
After-tax WACC | 5.4% | 8.4% |
Selected WACC | 6.9% | |